Inventor · disambiguated record
John Gordon Allen
Also filed as: ALLEN JOHN · ALLEN JOHN G · ALLEN JOHN GORDON
26 granted patents·13 pending applications·308 citations·filing 2005–2025
95Inventor score
Top patents by PatentIndex Score
39 records- 0198US11905281B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2020·Granted Feb 20, 2024·13 cites·16 claims
- 0298US11766436B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2021·Granted Sep 26, 2023·11 cites·19 claims
- 0398US11090304B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 17, 2021·33 cites·3 claims
- 0498US10519146B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2018·Granted Dec 31, 2019·81 cites·33 claims
- 0597US11096939B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 24, 2021·24 cites·30 claims
- 0696US12083121B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2022·Granted Sep 10, 2024·7 cites·5 claims
- 0796US11285156B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2019·Granted Mar 29, 2022·16 cites·4 claims
- 0894US7897619B2Heterocyclic modulators of PKBAMGEN INC·Filed 2008·Granted Mar 1, 2011·42 cites·41 claims
- 0994US7514566B2Thiazole compounds and methods of useAMGEN INC·Filed 2007·Granted Apr 7, 2009·38 cites·48 claims
- 1093US12440491B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2023·Granted Oct 14, 2025·1 cites·4 claims
- 1193US7919504B2Thiadiazole modulators of PKBAMGEN INC·Filed 2008·Granted Apr 5, 2011·30 cites·16 claims
- 1288US2025381187A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 1384US2024174660A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2023·Application pending·0 cites
- 1480US7713979B2Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2005·Granted May 11, 2010·4 cites·7 claims
- 1580US2024327461A1Apelin polypeptidesAMGEN INC·Filed 2024·Application pending·0 cites
- 1677US8022062B26-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonistsLILLY CO ELI·Filed 2005·Granted Sep 20, 2011·4 cites·22 claims
- 1775US12459932B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Nov 4, 2025·1 cites·34 claims
- 1875US12441736B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Oct 14, 2025·1 cites·31 claims
- 1974US11807693B2Apelin polypeptidesAMGEN INC·Filed 2021·Granted Nov 7, 2023·0 cites·6 claims
- 2071US8084479B2Thiazole compounds and methods of useZENG QINGPING·Filed 2009·Granted Dec 27, 2011·1 cites·20 claims
- 2170US2020055845A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2019·Application pending·0 cites
- 2269US7816349B2Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Oct 19, 2010·1 cites·16 claims
- 2367US11732266B2RNAi constructs for inhibiting ASGR1 expression and methods of use thereofAMGEN INC·Filed 2020·Granted Aug 22, 2023·0 cites·34 claims
- 2465US2024409557A15,6-fused and 6,6-fused bicyclic alcohols and ethers and compositions for use as 15-prostaglandin dehydrogenase modulatorsAMGEN INC·Filed 2024·Application pending·0 cites
- 2559US10941182B2Apelin polypeptidesAMGEN INC·Filed 2015·Granted Mar 9, 2021·0 cites·26 claims
- 2658US2014199728A1Methods of using cell-cycle inhibitors to modulate one or more properties of a cell cultureAMGEN INC·Filed 2013·Application pending·0 cites
- 2758US2025179077A1Quinazoline compounds and uses thereof as inhibitors of mutant kras proteinsAMGEN INC·Filed 2023·Application pending·0 cites
- 2858US2015353542A1Methods of using cell-cycle inhibitors to modulate one or more properties of a cell cultureAMGEN INC·Filed 2013·Application pending·0 cites
- 2957US10870856B2RNAi constructs for inhibiting ASGR1 expression and methods of use thereofAMGEN INC·Filed 2017·Granted Dec 22, 2020·0 cites·36 claims
- 3056US2018087079A1Methods of using cell-cycle inhibitors to modulate one or more properties of a cell cultureAMGEN INC·Filed 2017·Application pending·0 cites
- 3152US12435058B2KIF18A inhibitorsAMGEN INC·Filed 2020·Granted Oct 7, 2025·0 cites·21 claims
- 3251US2022289724A1Kif18a inhibitorsAMGEN INC·Filed 2020·Application pending·0 cites
- 3346US9328134B2Carbohydrate phosphonate derivatives as modulators of glycosylationAMGEN INC·Filed 2014·Granted May 3, 2016·0 cites·38 claims
- 3443US7994163B26-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonistsLILLY CO ELI·Filed 2006·Granted Aug 9, 2011·0 cites·5 claims
- 3543US2010184764A1Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2010·Application pending·0 cites
- 3639US8580780B26 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonistALLEN JOHN GORDON·Filed 2011·Granted Nov 12, 2013·0 cites·21 claims
- 3739US2008214621A1Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1AICHER THOMAS DANIEL·Filed 2005·Application pending·0 cites
- 3837US2011263647A1Fluoroisoquinoline substituted thiazole compounds and methods of useAMGEN INC·Filed 2010·Application pending·0 cites
- 3936US8420631B26-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonistsALLEN JOHN GORDON·Filed 2006·Granted Apr 16, 2013·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when John Gordon Allen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →